(203) 815-5782
balmassian@carogencorp.com
Home
About
About Us
Management
AVIDIO
AVIDIO
Oncology: CARG-2020
CARG-201 for HBV
Investors and Funding Resources
News
Contact
Novel Immunomodulatory Virus CARG-2020 for Recurrent Ovarian Cancer
Novel Immunomodulatory Virus CARG-2020 for Recurrent Ovarian Cancer
CaroGen Corporation
CaroGen Corporation
(203) 815-5782
balmassian@carogencorp.com
